WebJul 9, 2024 · Abbott's Alere has agreed to pay $38.75 million to resolve allegations that it billed Medicare for defective rapid point-of-care testing devices. The Department of Justice accused Alere of selling its INRatio blood coagulation monitoring systems with a known defect from 2008 to 2016. Alere allegedly made a "business decision" to close its ... WebAug 2, 2024 · That investigation, among other revelations that came to light after Abbott first agreed to buy Alere, drove Abbott to take Alere to court in an effort to get out of the merger. Still, Abbott's diagnostics business has benefited from the technology it acquired through the $5.3 billion deal.
Abbott to Acquire Alere, Becoming Leader in Point of …
WebSep 28, 2024 · The settlement with Alere resolved an investigation that began in 2015 before Abbott Laboratories agreed to buy the Waltham, Massachusetts-based company in a $5.3 billion deal expected to close ... WebSep 8, 2016 · After announcing the Alere deal, Abbott agreed in April to a $25 billion acquisition of rival St. Jude Medical STJ.N, which Alere has said is the reason Abbott no longer wants to buy Alere. news top stories science
Abbott Labs/Alere: before and after Financial Times
WebOct 3, 2024 · Paul, Weiss represented Alere Inc. in its acquisition by Abbott Laboratories. Under the terms of the deal, Alere stockholders received $51 per share of common stock … WebSep 29, 2024 · With the addition of Alere, Abbott has approximately $7 billion in diagnostics sales worldwide, including approximately $2.5 billion in point of care testing. About … WebApr 14, 2024 · Abbott agreed to buy Alere in February 2016, a few months before it also signed a deal to purchase St. Jude Medical, a maker of cardiovascular devises, for $25 … new stop smoking medications